Oral tobacco products: Preference and effects among smokers

Drug and Alcohol Dependence

Volumn 118, Issue 2-3, 2011, Pages 230-236

  Hatsukami, Dorothy K ^a   Jensen, Joni ^a   Anderson, Amanda ^a   Broadbent, Berry ^b   Allen, Sharon ^c   Zhang, Yan ^d   Severson, Herb ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b OREGON RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cessation; Oral tobacco products; Tobacco product testing

Indexed keywords

NICOTINE;

ADULT; ARIVA; ARTICLE; ATTITUDE; CAMEL SNUS; CONTROLLED STUDY; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; GENERAL SNUS; HUMAN; MALE; MARLBORO SNUS; OUTCOME ASSESSMENT; PLANT PRODUCT; PRIORITY JOURNAL; SAMPLING; SATISFACTION; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; STONEWALL; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HUMANS; MALE; NICOTINE; QUESTIONNAIRES; SMOKING; SMOKING CESSATION; TOBACCO, SMOKELESS;

NICOTIANA TABACUM;

EID: 80053572550     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.03.026     Document Type: Article

References (29)

1. Accortt N.A., Waterbor J.W., Beall C., Howard G. Chronic disease mortality in a cohort of smokeless tobacco users. Am. J. Epidemiol. 2002, 156:730-737.
2. Bates C., Fagerstrom K., Jarvis M.J., Kunze M., McNeill A., Ramstrom L. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health. Tob. Control 2003, 12:360-367.
3. Blank M.D., Eissenberg T. Evaluating oral noncombustible potential-reduced exposure products for smokers. Nicotine Tob. Res. 2010, 12:336-343.
4. Cobb C.O., Weaver M.F., Eissenberg T. Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers. Tob. Control 2010, 19:367-373.
5. Ebbert J.O., Rowland L.C., Montori V., Vickers K.S., Erwin P.C., Dale L.C., Stead L.F. Interventions for smokeless tobacco use cessation. Cochrane Database Syst. Rev. 2004, 1-22.
6. Fagerstrom K.O., Schildt E.B. Should the European Union lift the ban on snus? Evidence from the Swedish experience. Addiction 2003, 98:1191-1195.
7. Gartner C., Hall W. Harm reduction policies for tobacco users. Int. J. Drug Policy 2010, 21:129-130.
8. Gartner C.E., Hall W.D., Vos T., Bertram M.Y., Wallace A.L., Lim S.S. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 2007, 369:2010-2014.
9. Hatsukami D.K., Hanson K., Briggs A., Parascandola M., Genkinger J., O'Connor R., Shields P. Clinical trials methods for evaluation of potential reduced exposure products. Cancer Epidemiol. Biomarkers Prev. 2009, 18:3143-3195.
10. Hatsukami D., Kotlyar M., Hertsgaard L.A., Zhang Y., Carmella S.G., Jensen J.A., Allen S.S., Shields P.G., Murphy S.E., Stepanov I., Hecht S.S. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction 2010, 105:343-355.
11. Hatsukami D., Lemmonds C., Tomar S. Smokeless tobacco use: harm reduction or induction approach?. Prev. Med. 2004, 38:309-317.
12. Heatherton T.F., Koslowski L.T., Frecker R.C., Fagerström K.-O. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br. J. Addict. 1991, 86:1119-1127.
13. Hughes J., Hatsukami D. Errors in using tobacco withdrawal scale. Tob. Control 1998, 7:92-93.
14. Hughes J.R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch. Gen. Psychiatry 1986, 43:289-294.
15. Kotlyar M., Hertsgaard L.A., Lindgren B.R., Jensen J.A., Carmella S.G., Stepanov I., Murphy S.E., Hecht S.S., Hatsukami D.K. Effects of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study. Cancer Epidemiol. Biomarkers Prev. 2011, 20:91-100.
16. Kotlyar M., Mendoza-Baumgart M.I., Li Z.Z., Pentel P.R., Barnett B.C., Feuer R.M., Smith E.A., Hatsukami D.K. Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge. Tob. Control 2007, 16:138-142.
17. Lund K.E., McNeill A., Scheffels J. The use of snus for quitting smoking compared with medicinal products. Nicotine Tob. Res. 2010, 12:817-822.
18. Ramstrom L.M., Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob. Control 2006, 15:210-214.
19. Schneider N.G., Olmstead R.E., Nides M., Mody F.V., Otte-Colquette P., Doan K., Patel S. Comparative testing of 5 nicotine systems: initial use and preferences. Am. J. Health Behav. 2004, 28:72-86.
20. Severson H.H., Forrester K.K., Biglan A. Use of smokeless tobacco is a risk factor for cigarette smoking. Nicotine Tob. Res. 2007, 9:1331-1337.
21. Silagy C., Lancaster T., Stead L., Mant D., Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 2004, 3:CD000146.
22. Stegmayr B., Eliasson M., Rodu B. The decline of smoking in northern Sweden. Scand. J. Public Health 2005, 33:321-324.
23. Stenbeck M., Hagquist C., Rosen M. The association of snus and smoking behaviour: a cohort analysis of Swedish males in the 1990s. Addiction 2009, 104:1579-1585.
24. Stepanov I., Jensen J., Hatsukami D., Hecht S.S. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob. Res. 2008, 10:1773-1782.
25. Teo K.K., Ounpuu S., Hawken S., Pandey M.R., Valentin V., Hunt D., Diaz R., Rashed W., Freeman R., Jiang L., Zhang X., Yusuf S. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006, 368:647-658.
26. Tomar S.L. Snuff use and smoking in U.S. men: implications for harm reduction. Am. J. Prev. Med. 2002, 23:143-149.
27. Tomar S.L. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob. Res. 2003, 5:561-569.
28. Tomar S.L. Epidemiologic perspectives on smokeless tobacco marketing and population harm. Am. J. Prev. Med. 2007, 33:S387-S397.
29. Westman E., Levin E., Rose J. Smoking while wearing the nicotine patch: is smoking satisfying or harmful?. Clin. Res. 1992, 40:871A.